|
|
|
Insider
Information: |
Kango Sujay |
Relationship: |
EVP, Chief Commercial ... |
City: |
Bridgewater |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
19,108 |
|
Indirect Shares
|
3,598 |
|
|
Direct
Value |
$3,308,484 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
22,706 |
|
|
Total
Value |
$3,308,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Infinity Pharmaceuticals Inc |
INFI |
Chief Commercial Officer |
2016-12-13 |
599 |
2016-12-13 |
3,598 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
EVP, Chief Commercial ... |
2021-09-27 |
18,509 |
2018-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
SVP, Chief Commercial Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, Chief Commercial Officer |
|
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,050 |
10,050 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, Chief Commercial Officer |
|
2020-01-03 |
4 |
AS |
$51.27 |
$24,657 |
D/D |
(480) |
9,570 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, Chief Commercial Officer |
|
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,369 |
15,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2020-02-13 |
4 |
AS |
$94.09 |
$55,987 |
D/D |
(595) |
15,344 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-01-04 |
4/A |
OE |
$40.61 |
$406,100 |
D/D |
10,000 |
13,987 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-01-04 |
4 |
D |
$124.31 |
$168,689 |
D/D |
(1,357) |
13,987 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-01-04 |
4 |
AS |
$123.90 |
$1,253,759 |
D/D |
(10,000) |
3,987 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,409 |
19,396 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-02-12 |
4 |
D |
$130.87 |
$116,082 |
D/D |
(887) |
18,509 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-03-02 |
4 |
OE |
$40.61 |
$203,050 |
D/D |
5,000 |
24,396 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-03-02 |
4 |
AS |
$135.48 |
$680,059 |
D/D |
(5,000) |
19,396 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-09-21 |
4 |
AS |
$150.03 |
$750,150 |
D/D |
(5,000) |
18,509 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-09-21 |
4 |
OE |
$40.61 |
$203,050 |
D/D |
5,000 |
23,509 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-09-27 |
4 |
OE |
$40.61 |
$203,050 |
D/D |
5,000 |
23,509 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
EVP, Chief Commercial Officer |
|
2021-09-27 |
4 |
AS |
$175.00 |
$875,000 |
D/D |
(5,000) |
18,509 |
0 |
% |
|
INFI |
Infinity Pharmaceuticals ... |
Chief Commercial Officer |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,599 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Chief Commercial Officer |
|
2016-12-12 |
4 |
S |
$1.30 |
$32,612 |
D/D |
(25,009) |
50,590 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Chief Commercial Officer |
|
2016-12-13 |
4 |
S |
$1.25 |
$63,259 |
D/D |
(49,991) |
599 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|